Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Novartis AG Common Stock (NY:NVS)

154.03 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	152.80 (100)
Ask (Size)	157.99 (100)
Prev. Close	154.03
Today's Range	154.03 - 154.03
52wk Range	97.72 - 170.46
Shares Outstanding	N/A
Dividend Yield	2.59%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring

April 03, 2026

WASHINGTON, D.C. — In a move that has sent shockwaves through the global healthcare industry, President Trump signed a sweeping executive order yesterday, April 2, 2026, imposing a baseline 100% tariff...

Via MarketMinute

Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗

April 01, 2026

Legend Biotech (LEGN) Q4 2024 Earnings Transcript

Via The Motley Fool

Performance

YTD	+11.2%	+11.2%
1 Month	-4.3%	-4.3%
3 Month	+11.7%	+11.7%
6 Month	+16.5%	+16.5%
1 Year	+45.5%	+45.5%

More News

Novartis AG-Sponsored ADR (NYSE:NVS): A Methodical Pick for Steady Dividend Income ↗

March 13, 2026

Via Chartmill

Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗

April 01, 2026

Via The Motley Fool

Biogen's $5.6 Billion Acquisition of Apellis: A Strategic Pivot into Rare Kidney Diseases

March 31, 2026

Via MarketMinute

Could Investing $10,000 in VYMI Make You a Millionaire? ↗

March 30, 2026

Via The Motley Fool

Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline ↗

March 27, 2026

Via Benzinga

International ETFs: EEM and IEFA Offer Distinct Global ETF Choices ↗

March 27, 2026

Via The Motley Fool

Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data

March 26, 2026

Via MarketMinute

The Second Act: A Deep-Dive into Corcept Therapeutics and the FDA Approval of Lifyorli

March 26, 2026

Via Finterra

The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition

March 25, 2026

Via Finterra

Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF ↗

March 24, 2026

Via The Motley Fool

3 ETFs Built for the Volatile Market We're Seeing in March 2026 ↗

March 22, 2026

Via The Motley Fool

Novartis Strikes $3 Billion Deal For Next-Gen Breast Cancer Drug ↗

March 20, 2026

Via Benzinga

The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms

March 18, 2026

Via MarketMinute

Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients ↗

March 16, 2026

Via Benzinga

VYMI: This International ETF Could Help You Earn Higher Dividends ↗

March 12, 2026

Via The Motley Fool

3 ETFs to Avoid as Oil Shock Hits Markets ↗

March 12, 2026

Via MarketBeat

Vertex Pharmaceuticals Surges as Breakthrough Kidney Data Sets New Gold Standard for IgA Nephropathy

March 10, 2026

Via MarketMinute

Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity

March 10, 2026

Via Finterra

Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now ↗

March 03, 2026

Via The Motley Fool

As Investors Flee U.S. Equities, This Global ETF Is Outperforming ↗

March 02, 2026

Via MarketBeat

Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement ↗

February 28, 2026

Via Benzinga

Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy

February 26, 2026

Via MarketMinute

Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies ↗

February 25, 2026

Via The Motley Fool

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?

Yes, Novartis AG Common Stock is publicly traded.

What exchange does Novartis AG Common Stock trade on?

Novartis AG Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Novartis AG Common Stock?

The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange

What is the current price of Novartis AG Common Stock?

The current price of Novartis AG Common Stock is 154.03

When was Novartis AG Common Stock last traded?

The last trade of Novartis AG Common Stock was at 04/02/26 07:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.